chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized (9.27.21-present);  COVID-19 positive (9.20.21);  fully vaccinated  HISTORY OF PRESENT ILLNESS: a 72 y.o. female hx malignant hepatoma s/p liver tansplant on chronic immunosuppression with tacrolimus and prednisone, SLE, SCC of left upper lobe of lung, CKD3, DM2 who presents today with crampy epigastric non-radiating abdominal pain associated with nausea, vomiting and diarrhea. She has had this pain for some time but It has been acutely worse the past 24 hours. Daughter estimates >20 episodes of vomiting and loose watery non-bloody stools. Unable to manage symptoms at home with Zosyn so came to the ED.   She was recently admitted to CRS 8/23-8/29 with perforated sigmoid diverticulitis. She was managed without surgery on IV Zosyn transitioned to Augmentin at discharge. She was having persistent symptoms of nausea and left sided abdominal pain so CT abdomen and pelvis completed on 9/20 showing residual distal descending colon diverticulitis with partial improvement and no abscess. She was placed back on Augmentin for another week. She also had COVID 19 testing completed on 9/20 which was positive and she had monoclonal antibody infusion on 9/24/2021. She had received both COVID19 vaccinations and does not know how or exact time frame as to when she contracted this virus.   On arrival she had rectal temp 37.8, HR 103, RR 28, with O2 saturations mid to upper 90's. Her significant lab findings include bicarb 17, BUN 21, creat 2.2, lactic acid 3.9, WBC 9.33.  CT abdomen and pelvis was repeated today with continued findings of localized perforated diverticulitis mildly improved from 9/20/21 and questionable mild superimposed colitis. In ED given IV morphine, IV zofran, 2Liter IVF. ASSESSMENT / PLAN: Acute kidney injury Lactic acidosis -creat today 2.2; baseline 1.2-1.4 -lactic acid 3.9 to 2.2 with IVF -continue IV fluid resuscitation NS 0.9% at 100ml/hr -trend CMP, lactic acid until normalizes   Acute on chronic abdominal pain Nausea, vomiting and diarrhea -CT abdomin/pelvis with findngs of localized perforated diverticulitis mildly improved from 9/20/21 and questionable mild superimposed colitis -check stool studies including c diff -may be related to COVID 19 vs antibiotic use vs diverticulitis/colitis -completed prolonged course of augmentin -TIGAN for nausea given prolonged QTc -hold further antibiotic treatment pending stool studies; consult Infectious disease for recommendations of continuing antibiotics   Positive COVID-19 testing on 9/20/21 -status post monoclonal antibody infusion on 09/24 -trend CMP, CRP, CBC
CLIENTS DATE OF BIRTH ON CONSENT FORM LISTED BY PARENT. THUS MAKING HER ELIGIBLE FOR SECOND DOSE OF PEDS PFIZER. AT SOME POINT THE CHILD'S DOB WAS UPDATED ON OUR ONLINE DATABASE, MAKING HER INELIGIBLE FOR PEDS PHIZER. THE PARENT CONFIRMED THE DOB OVER THE PHONE. STATED THE CHILD SUFFERED NO ADVERSE REACTIONS TO RECEIVING THE VACCINE EARLY.
Red, itchy, swollen, hot, painful spot at the injection site; Red, itchy, swollen, hot, painful spot at the injection site; Red, itchy, swollen, hot, painful spot at the injection site; Red, itchy, swollen, hot, painful spot at the injection site; Red, itchy, swollen, hot, painful spot at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 04Mar2021 at 15:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The medical history included allergy to mango skin which causes poison ivy type rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included bupropion hydrochloride (WELLBUTRIN), buspirone hydrochloride (BUSPAR), vitamins (unspecified) and birth control pills (unspecified); all taken from unknown dates for unknown indications and unknown if ongoing. On 04Mar2021 at 17:00, the patient experienced red, itchy, swollen, hot, painful spot at the injection site. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red, itchy, swollen, hot, painful spot at the injection site was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Given a dose from an expired vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given a dose from an expired vial) in a 24-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2022 at 12:04 PM, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given a dose from an expired vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Given a dose from an expired vial) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.   For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.
Had arm pain in area of vaccine immediately after vaccine given. Later that day & 2 days following it still hurt the same. Since then has had ongoing pain worse in morning, an indurated area where vaccine seemed to be given; beneath the capsule & pain with range of motion. Limiting her activities: can't work out b/c of arm pain worsened by deltoid muscle movements. Seen for this concern 13 days after vaccination w/o improvement w/ ADVIL.
I had a fever and chills at night and also a headache, I felt nauseous, vomiting and difficulty breathing. I could not sleep that night after I received my vaccine. I decided not to go the ER and slept it off I woke up much better next morning. I saw a Doctor a couple of days later because I had shortness of breathing and a high heart rate while I was at work. He just told me to take it slowly at work. No meds.  I then started working part-time for some weeks and am being introduced again now to my regular scheduled.
Patient received vaccine. Left counseling to sit in observation room. Patient then fainted for about 20 seconds. After, he felt nauseous and had a headache. Continued to observe patient for 30 minutes after fainting and he did begin to feel better. Patient did start to feel better and Dad decided to take him on home. Patient did state that he had not eaten much today.
Information has been received from a 69 year old female patient who "2 or 3 years ago" was vaccinated with a dose of PNEUMOVAX (manufacturer unknown). Secondary suspect vaccine given on the same day included influenza virus vaccine (unspecified). It was reported that "2 or 3 years ago" the patient experienced an allergic reaction like swelling after receiving PNEUMOVAX and influenza virus vaccine together and was hospitalized for couple days. It was reported that the patient had recovered on an unspecified date. Additional information has been requested.
CLIENT DEVELOPED ERYTHEMA (10 CM IN DIAMETER) TO INJECTION SITE TO RIGHT ANTERIOR THIGH.
Pt with shivering, body aches, loss of energy and feeling tired after dialysis treatment.  Patient sent to ER via EMS.  Patient went to hospital.  Patient was discharged form the ER.  No admission.
Vaccine given at 10:30 AM and first symptoms between 2 to 4 hours afterwards were normal for flu vaccine (sore arm, mild headache). During the 5th to 7th hours, beginning symptoms of vision changes (blurriness) and dizziness began to manifest. By 6:00 PM and onward, symptoms became strong, including extreme dizziness while sitting, inability to focus eyes, disorientation, anxiety, numbness, dry mouth, chest tightness, and mild muscle weakness. Numbness initially presented in legs, hips and spine, spreading to face and occasionally in the tongue. Water intake was normal and I was not dehydrated, yet I still experienced dry mouth. Food intake was normal. Between late afternoon (approx. 5PM) and 4:00 AM on the morning following vaccination, symptoms continued to be intense and concerning. Around midnight, during symptoms, I reported my condition to my doctor's office using the online message system. After 4:00 AM I fell asleep. Waking 6 to 7 hours later, symptoms had become mild and mainly consisted of mild occasional dizziness and vision changes. Vision changes continued throughout Friday and Saturday but did not prevent walking or driving. On Saturday evening, about 60 hours after vaccination, I began to have a mild scratchy throat. By 8:00 AM Sunday morning, the scratchy throat had become severe and required pain medication. On Monday night (09/07/2015) symptoms of chest pain, arm and shoulder discomfort, and cough were present.
Information has been received from a company (SR# 142189577) concerning a 59 year old female who, on an unspecified date, was vaccinated with a dose of Pneumovax 23.  Concomitant therapy included REBIF.  Subsequently the patient "experienced achy symptoms and legs feel weak."  No further information is available.
On 11/08/2021 around 8:30 at Started to get a bad headache, low grade, fever and dizziness with some body aches. This is day 2
This spontaneous pregnancy report as received from a other health professional refers to a female patient of unknown age with vaccination. On 13-MAR-2014 the patient was vaccinated with M-M-R II, .5 ml, subcutaneous. No relevant medical history was reported. Concomitant therapies included Tdap. After a negative urine HCG test, but has been subsequently determined to be pregnant by serum HCG test. The consumer became pregnant with LMP of 18-FEB-2014 and EDD of 25-NOV-2014. Initial exposure to M-M-R II was at 3 week(s). On an unknown date the patient experienced pregnant. No treatment information was reported. The outcome of pregnant is unknown. The reporter considered pregnant to be not related to M-M-R II. No further information is available.
This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. On 03-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
This is a spontaneous report received from a consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration to left arm on 17Mar2021 at 18:15 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. Medical history of the patient included diabetic. Concomitant medications were not reported. The patient had allergies to sulpha drug. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received EFFECTOR XR and XIGDUO medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was tested for COVID-19. On 18Mar2021 (day after the vaccine), the patient experienced injection site sore in arm hurt (vaccination site pain). On 19Mar2021, the patient had sore throat and cough, sneezing, chills, head and body aches. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events vaccination site pain, sore throat, cough, sneezing, chills, headache and body aches was not resolved at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
The patient had a syncopal event, followed by flushing and vomitting. He received the vaccine at 9:30am and the event occurred at 9:32am and lasted 30 seconds. He then became extremely flushed and dizzy. He was given a cool compress and bottle of water. I observed him for 7 minutes and then he began to vomit. After vomiting, I observed him for 15 more minutes, personally, and then had him wait in our waiting area for 15 additional minutes.
pregnant patient received two doses; received two doses; This prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of vaccine exposure during pregnancy in a 34-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2021-2022 season) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Influenza Vaccine Quadrivalent Pre-Filled Syringe Device) injection syringe for prophylaxis, Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2021-2022 season) for prophylaxis and flu seasonal qiv dresden pre-filled syringe device (Influenza Vaccine Quadrivalent Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 2nd dose of Influenza vaccine Quadrivalent 2021-2022 season, Influenza Vaccine Quadrivalent Pre-Filled Syringe Device, the 1st dose of Influenza vaccine Quadrivalent 2021-2022 season and Influenza Vaccine Quadrivalent Pre-Filled Syringe Device. The patient's last menstrual period was on an unknown date and estimated date of delivery was 7th November 2021. The patient received Influenza vaccine Quadrivalent 2021-2022 season at an unknown time during the pregnancy. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent 2021-2022 season, Influenza Vaccine Quadrivalent Pre-Filled Syringe Device, Influenza vaccine Quadrivalent 2021-2022 season and Influenza Vaccine Quadrivalent Pre-Filled Syringe Device, the patient experienced vaccine exposure during pregnancy and extra dose administered. On an unknown date, the outcome of the vaccine exposure during pregnancy and extra dose administered were unknown. The pregnancy was ongoing.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The pregnant patient received two doses of either Fluarix or Flulaval approximately one week apart, which led to vaccine exposure during pregnancy and extra dose administered. The reporter consented to follow up.
Patient got sick a day after vaccination.  He developed further COVID-like symptoms and was diagnosed by PCP with COVID 3 days after vaccination.  He is doing well now.
Immunization Healthcare Branch was contacted by Occupational Health staff for assistance with VAERS for this patient and guidance on use of last oral typhoid dose in association with below symptoms. This 56 year old retired employee, received booster vaccinations on 3/10/2015 to include Yellow Fever and Meningococcal vaccines. He started his oral Typhoid vaccine on 3/11/2015 in compliance with employment immunization requirements. He advised he had received these same vaccines with IM Typhoid during his 23 year career without any reactions. Over the next few days he began to experience a runny nose, nasal congestion and fever noticing with 2nd and 3rd dose of oral typhoid (3/15/2015) his symptoms worsened (also day 5 after YF/MEN). He presented to PCP c/o persistent fever ranging 101-103.1F, chills, night sweats, generalized malaise, URI like symptoms (runny nose, congestion, post nasal drip, non-productive cough), body aches and episodic headaches (diffuse-facial). His complained urine was tea colored with first void but cleared after 4 liters water/Gatorade during the day. His wife reported he did not seem himself and was not "thinking clearly" as he did prior to his vaccinations. On 3/20/15 he continued alternating MOTRIN/TYLENOL for persistent recurrent fevers which would go down to 100 deg F. His PCP advised his CXR was normal and he had mild elevation in AST (53) and ALT (54) and low BUN/Creat (7/1.1) with BUN/Cr ratio low at 7.4. His WBC was normal at 7.4, H/H low 12.4/35.3, plt 189, RBC 3.95 (MCV/MCH/RDW all normal). Lab values suggest dehydration. Further labs were ordered for salmonella typhi, blood cultures, and viral studies (CMV, HSV, enterovirus, EBV). He reported being unable to work and was on personal sick leave greater than 24 hours. A VAERS will be filed by IHB. 3/23/2015: He advised his fevers were 99 degree F between MOTRIN doses; he uses NYQUIL at night, has stopped TYLENOL usage and has stopped using decongestants because it makes his mucus taste bad. No antibiotic therapy was initiated with normal WBC and he did not take the final dose of oral typhoid. He was eating well but had a queasy stomach at times due to post nasal drip, his night sweats were less and no headaches (last headache was 3/22/2015). 3/24/2015 he reported his temperature was stable at 98-99 deg F and he stopped use of MOTRIN. However, his temperature elevated to 101 degree F and he restarted use of his MOTRIN. He still has nasal congestion and post nasal drip with a mild cough, otherwise is doing fine. He advised his wife now has a cold. He is scheduled to see Infectious disease provider on Thursday 3/26/2015. 3/31/2015 he advised he no longer has a fever/temperature; however he continues with a mild cough. He advised he did return to work.
Exchange student, 3-20-13 - diarrhea, cramping, vomiting - on 3/23/13 he was admitted to hospital with dehydration - still having N, V, and D. Discharged 3/25 - p.m no more vomiting, 3/26 started cramping, diarrhea and V again. Admitted to hospital on 3/29/13 - 4/6/13. Had PIC line in till 4/18/13. 4/22/13 - back to school - finally. Still weak and tired.
The ring finger on the left hand became numb on Saturday, 4/17/21, about 24 hours after the vaccination time of 4/16/21 at 1:30pm.
Patient received Tdap on September13, 2017. She returned for additional vaccines today, 09/20/2017. Her left arm showed erythema of 65 x 70 with heat that had only started the day before about 5pm. She was seen by Dr. It was unusal that the reaction waited 6 days before it appeared. We are not aware of other possible causes.
patients received a dose of a vial after 12 hours of initial puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients received a dose of a vial after 12 hours of initial puncture) in a 34-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients received a dose of a vial after 12 hours of initial puncture). On 15-Dec-2021, EXPIRED PRODUCT ADMINISTERED (patients received a dose of a vial after 12 hours of initial puncture) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   NO Concomitant drug reported. NO Treatment drug reported  Vial puncture on 11 Nov 2021, dose given, kept in refrigerator after puncture.   This case was linked to MOD-2021-418964 (Patient Link).
Information has been received from a company representative concerning a patient who was vaccinated with one dose of varicella virus vaccine live. Subsequently, the patient developed "vaccine virus". The patient sought unspecified medical attention. Additionally it was reported that the patient's aunt also developed a "full blown case". Additional information has been requested.
This spontaneous report was received from 59 year old female patient with diabetes, who was reporting on herself. She had no known drug reactions or allergies and no information regarding the her concomitant medications was provided. On 31-OCT-2018, the patient was vaccinated with an expired dose of PNEUMOVAX 23 injection, intramuscularly, (exact dose, lot number and expiration date were not reported). On the same date, she experienced normal shot pain and had a hard time sleeping. She that she spoke with her doctor who told her to came back to get re-vaccinated". And at the reporting time, she was considering re-vaccination. No lab diagnostics or studies were performed and no treatment was given for the events. The patient mentioned that an unspecified flu shot also gave her normal shot pain (timeframe unspecified). At the time of the report, the patient did not recover from the events. The causality assessment was not provided.
Arm red and swollen from shoulder to elbow, raised 1/2 inch areas, hot, firm.
Pt feels dizzy on the way to the observation area. EMT provides oxygen. paramedics called and transport to hospital
Flu; Fever; blisters all around her mouth and inside her mouth.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA (non-serious), outcome "unknown", described as "Flu"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; ORAL MUCOSAL BLISTERING (non-serious), outcome "unknown", described as "blisters all around her mouth and inside her mouth.".  Additional information: patient took the COVID 19 shot. Patient stated she got the flu and fever after getting the vaccine. Last sunday she got blisters all around her mouth and inside her mouth.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
My son first received the ActHIB vaccine in his right arm/shoulder. There were no reactions outside of mild/normal with that vaccine. However, then he received the PCV13 vaccine in his left arm/shoulder. By the time we left the Health Department, his left shoulder showed redness at the injection site. He began developing a large, hard knot at the injection site. He would cry out in pain if you touched it. I began giving him epsolm salt baths to help. For two weeks after the PCV13 shot, he had a large, noticeable knot in his left shoulder at the injection site. His vocabulary was very well-developed for a two year old, and he expressed to me the immense amount of soreness and pain that he was in. I had to go to extreme lengths when dressing him as to not disturb his shoulder. At the two weeks mark after injection, the large, hard knot in his shoulder began to shrink. However, he was still terrified and in pain if you tried to go near his left shoulder. By three weeks after injection, it was a small, barely there knot in his left shoulder. It took a full month for it to completely heal. The epsom salt bath did make a positive difference in promoting healing and reducing swelling of the arm.
Patient fainted. She recovered on her own with water. This has happened in the past with vaccine administration.